Newsroom

Sorted by: Latest

-

Riassunto: SBC Medical annuncia la chiusura dell'offerta pubblica secondaria annunciata in precedenza del valore di 3,1 milioni di azioni ordinarie

IRVINE, Calif.--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“la Società”), un'organizzazione di servizi di gestione che opera un'ampia gamma di attività in franchising in diversi settori medici ha annunciato oggi la chiusura della sua offerta pubblica secondaria con garanzia di collocamento precedentemente annunciata, relativa a 3.100.000 azioni ordinarie della Società da parte del Dr. Yoshiyuki Aikawa (l'“Azionista venditore”) al prezzo pubblico di offerta di 3,25 d...
-

Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 4/21/2026 Issue ¦ QNB Finance Ltd - Series 396 USD 27,000,000 FRN due January 2027     ISIN Number ¦ XS2438701513 ISIN Reference ¦ 243870151 Issue Nomin USD ¦ 27000000 Period ¦ 1/28/2026 to 4/28/2026   Payment Date 4/28/2026 Number of Days ¦ 90 Rate ¦ 4.68825   Denomination USD ¦ 1000   ¦ 27000000   ¦       Amount Payable per Denomination ¦ 11.72   ¦ 316456.88   ¦       Bank of New York     Rate Fix...
-

PartsTrader Announces Leadership Transition as Mark Lindner Named Executive Vice President and General Manager

CHICAGO--(BUSINESS WIRE)--PartsTrader, an Enlyte company and an industry leading parts procurement marketplace, announced a leadership transition as Mark Lindner steps into an expanded role as Executive Vice President and General Manager, leading the PartsTrader organization into its next phase of growth and innovation. In this role, Lindner will also serve as a member of Enlyte's executive leadership team. This leadership transition follows the retirement of Steve Messenger, who has served as...
-

Kyna Fong of Elation Health Named Entrepreneur Of The Year® 2026 Bay Area Finalist by EY US

SAN FRANCISCO--(BUSINESS WIRE)--Kyna Fong, PhD, co-founder and CEO of Elation Health, has been named a finalist for the Entrepreneur Of The Year® 2026 Bay Area Award by Ernst & Young LLP (EY US). Now in its 41st year, the Entrepreneur Of The Year program celebrates the bold leaders who disrupt markets through the world’s most ground-breaking companies, revolutionizing industries and uplifting communities. The program honors entrepreneurs whose innovations drive economic growth and help shap...
-

SBC Medical anuncia el cierre de la venta secundaria de 3,1 millones de acciones ordinarias previamente informada

IRVINE, California--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (la “Compañía”), empresa de servicios de gestión que opera una amplia red de franquicias en distintos segmentos del sector médico, anunció hoy el cierre de la venta secundaria previamente informada de 3 100 000 acciones ordinarias, realizada por el Dr. Yoshiyuki Aikawa (el “Accionista Vendedor”), a un precio de oferta pública de USD 3,25 por acción. Los ingresos brutos obtenidos por el Accionista Vendedor...
-

Kallyope’s Phase 2b Study of Elismetrep, A Novel Approach for Treating Migraine, Presented at the American Academy of Neurology Annual Meeting

NEW YORK--(BUSINESS WIRE)--Kallyope is a late-stage biotechnology company focused on developing innovative migraine and metabolic disease therapies for health challenges faced by hundreds of millions of people globally. Today, the Company presented results from a Phase 2b dose-ranging and proof of concept study of elismetrep, a novel TRPM8 channel blocker and the only agent known to be in late-stage development for the acute treatment of migraine. The data were reported during an oral presentat...
-

SBC Medical gibt den Abschluss der zuvor angekündigten Sekundäremission von 3,1 Millionen Stammaktien bekannt

IRVINE, Kalifornien--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) („das Unternehmen“), eine Management-Service-Organisation, die eine breite Palette von Franchise-Unternehmen in verschiedenen medizinischen Bereichen betreibt, gab heute den Abschluss ihrer zuvor angekündigten, garantierten Sekundäremission von 3.100.000 Stammaktien des Unternehmens durch Dr. Yoshiyuki Aikawa (der „verkaufende Aktionär“) zum Emissionspreis von 3,25 US-Dollar pro Aktie bekannt. Der Erlös...
-

Sam Li of Thoropass Named Entrepreneur Of The Year® 2026 New York Finalist by EY US

NEW YORK--(BUSINESS WIRE)--Sam Li, CEO and co-founder of Thoropass, has been named a finalist for the Entrepreneur Of The Year 2026 New York Award by Ernst & Young LLP (EY US). Now in its 41st year, the Entrepreneur Of The Year program celebrates the bold leaders who disrupt markets through the world’s most ground-breaking companies, revolutionizing industries and uplifting communities. The program honors entrepreneurs whose innovations drive economic growth and help shape the future of bus...
-

SBC Medical annonce la clôture de son offre publique secondaire annoncée précédemment se montant à 3,1 millions d'actions ordinaires

IRVINE, Californie--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq : SBC) (« la Société »), une société de services de gestion qui exploite un large éventail d'entreprises franchisées dans divers domaines médicaux, a annoncé aujourd'hui la clôture de son offre publique secondaire garantie annoncée précédemment se montant à 3 100 000 actions ordinaires de la Société par le Dr Yoshiyuki Aikawa (l'« Actionnaire vendeur ») au prix de l'offre publique de 3,25 dollar par action. Le...
-

Xtrackers (IE) plc UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Dublin, 21 April 2026 This announcement is to inform the shareholders of the sub-funds listed in the table below (each a Sub-Fund, and together the Sub-Funds) (the Shareholders) on behalf of the board of directors of the Compa...